Potential therapeutic effect of stem cells on sensorineural hearing loss
Cet article est sous embargo et n'est visible que par les journalistes
Please login here
Emplacement:
Addresse
Heures d'ouverture:
Prix du ticket:
Type de contenu Matériels audiovisuels:
Début de la diffusion:
Durée de diffusion:
Titre de la publication:
Auteur:
Type de publication:
Date de publication:
Nombre de pages
Numéro ISBN:
Prix
Sensorineural hearing loss (SNHL) remains a global health challenge with limited regenerative therapeutic options. This review delineates advancements in stem cell-based therapies, emphasizing their potential to restore auditory function through cellular regeneration and molecular modulation. Stem cells, including mesenchymal (MSCs), induced pluripotent (iPSCs), and embryonic stem cells (ESCs), exhibit multilineage differentiation and paracrine signaling capabilities, enabling hair cell (HC) regeneration, spiral ganglion neuron (SGN) repair, and inflammation modulation. Cochlear organoid models derived from stem cells have advanced mechanistic studies, though challenges persist in replicating cochlear-specific HC phenotypes. Exosomes, as nanoscale bioactive vesicles, demonstrate enhanced biocompatibility and barrier penetration, effectively mitigating oxidative stress, apoptosis, and aminoglycoside ototoxicity while promoting HC survival. Gene-editing technologies, notably CRISPR-Cas9 and adeno‐associated virus (AAV) gene delivery systems, synergize with stem cell platforms to correct pathogenic mutations and engineer therapeutic cells for targeted inner ear repair. Preclinical studies highlight MSC transplantation and exosome administration in improving auditory thresholds and neuronal morphology, yet clinical translation faces hurdles including delivery precision, immune responses, and scalability. Current limitations in replicating cochlear cytoarchitecture and standardizing differentiation protocols necessitate further exploration of combinatorial strategies, such as integrating stem cell therapy with cochlear implants or medicament delivery systems. Future research needs prioritize optimizing cell lineage specification, enhancing exosome targeting, and validating long-term safety to realize the transformative potential of regenerative medicine in SNHL treatment.
The work entitled “Potential therapeutic effect of stem cells on sensorineural hearing loss” was published in Biophysics Reports (ahead of print in 2026).
DOI:
10.52601/bpr.2025.240017
Regions: Asia, China
Keywords: Science, Life Sciences
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
Cet article a été retiré. Les utilisateurs enregistrés peuvent contacter l'organisation pour plus de détails en se connectant